Brachytherapy for Recurrent Head and Neck Cancers
For patients facing recurrent head and neck cancers, treatment options can be limited due to previous radiation exposure. In such cases, brachytherapy offers a valuable salvage therapy, providing high-dose, localized radiation while sparing surrounding structures. The brachytherapy market is seeing increased adoption of this approach, particularly in specialized cancer centers with expertise in complex anatomical targeting.
Using image-guided placement of radioactive sources directly within or adjacent to the tumor, brachytherapy allows for re-irradiation without exceeding tolerance levels of nearby tissues like the spinal cord, salivary glands, or jawbone. This precision reduces toxicity risks and can significantly improve tumor control and patient survival. Combined with surgical debulking or immunotherapy, brachytherapy enhances the chances of long-term disease management in patients who have exhausted other treatment options.